Articles Referencing BCRX
Spectrum Pharma Reports 1Q Loss - Analyst Blog
5/14/2013, 10:12 am from Zacks.com in Investing, Business, Stocks
Spectrum Pharmaceuticals ( SPPI ) reported first
quarter of 2013 loss (including stock-based compensation but
excluding other special items) of 14 cents per share, narrower than
the... Read >>
Pre-Market Most Active for Apr 15, 2013 : S, LIFE, CLWR, MTU, C, BAC, NOK, JCP, BBRY, BCRX, QQQ, FB
4/15/2013, 8:39 am from NASDAQ.com News in News Headlines, Pre-market Most Active
The NASDAQ 100
Pre-Market Indicator is down -7.93 to 2,848.55. The total
Pre-Market volume is currently 53,456,348 shares traded.
The following are the
most active stocks for the... Read >>
Pre-Market Most Active for Apr 8, 2013 : BAC, BCRX, ARMH, QQQ, WFT, NXST, LUFK, ARCP, GM^B, MT, GNC, NOK
4/8/2013, 8:39 am from NASDAQ.com News in News Headlines, Pre-market Most Active
The NASDAQ 100
Pre-Market Indicator is up 4.06 to 2,775.81. The total
Pre-Market volume is currently 4,429,381 shares traded.
The following are the
most active stocks for the pre-market... Read >>
Spectrum Acquires Apaziquone Rights - Analyst Blog
2/4/2013, 5:00 pm from Zacks.com in Investing, Business, Stocks
Spectrum Pharmaceuticals ( SPPI ) recently
announced that it has regained development and commercial rights
for apaziquone from Allergan Inc. ( AGN ). Spectrum Pharma
reacquired the... Read >>
Synergy Starts SP-333 Phase I Study - Analyst Blog
1/29/2013, 4:50 pm from Zacks.com in Investing, Business, Stocks
Synergy Pharmaceuticals Inc. ( SGYP ) recently
initiated a phase Ib study on its inflammatory bowel disease (IBD)
candidate, SP-333. SP-333, a guanylate cyclase C (GC-C) agonist,... Read >>
Zacks Rank #1 Additions for Friday - Tale of the Tape
1/25/2013, 8:44 am from Zacks.com in Investing, Investing Ideas, Stocks
Here are 5 stocks added to the Zacks Rank #1 ("strong buy") List
today: AEterna Zentaris Inc. ( AEZS ) Aircastle Limited ( AYR ) BASF SE (ADR) ( BASFY ) BioCryst... Read >>
EU Nod for Novo Nordisk Drugs - Analyst Blog
1/23/2013, 6:14 pm from Zacks.com in Investing, Business, Stocks
Novo Nordisk ( NVO ) recently
announced that it has received approval in the EU (covering all 27
states) for its diabetes treatments, Tresiba (insulin degludec) and
Ryzodeg (insulin... Read >>
Positive CHMP Opinions for Novartis - Analyst Blog
1/23/2013, 4:50 pm from Zacks.com in Investing, Business, Stocks
Novartis ' ( NVS ) global eye care
division, Alcon, recently received a positive opinion from the
Committee for Medicinal Products for Human Use (CHMP) for Jetrea
(ocriplasmin). Jetrea is... Read >>
Questcor Acquires BioVectra - Analyst Blog
1/22/2013, 4:00 pm from Zacks.com in Investing, Business, Stocks
Questcor Pharmaceuticals Inc. ( QCOR ) recently
announced that it has completed the acquisition of BioVectera
Inc. for an immediate cash payment of CAD 50 million ($50.40
million... Read >>
Isis Pharma Updates on its Pipeline - Analyst Blog
1/11/2013, 3:20 pm from Zacks.com in Investing, Business, Stocks
Isis Pharmaceuticals, Inc. ( ISIS ) recently
provided an update on its pipeline. Isis Pharma boasts of a robust
pipeline. The company believes 5 of its pipeline candidates can get
approval... Read >>
Sanofi Updates on Pipeline - Analyst Blog
1/10/2013, 6:52 pm from Zacks.com in Investing, Business, Stocks
Sanofi ( SNY ) recently provided
an update on its pipeline. Sanofi boasts of a robust pipeline with
65 new molecular entities and vaccines in clinical development, of
which 17 are in phase... Read >>
10 Biotech Stocks Trading at Deep Discounts to Analyst Target Prices
10/31/2011, 9:18 pm from Kapitall in Investing, Investing Ideas, Stocks, Technology
(Written by Alexander Crawford. Target price data sourced from Thomson/First Call (via Yahoo! Finance)) Biotech companies deal with many uncertainties, and that directly translates to... Read >>
Wednesday Winners: Semis Continue Their Ascent
4/28/2010, 11:33 am from David Sterman in Investing, Stocks
Semiconductor stocks continue to deliver upside surprises.
Integrated Silicon Solution (Nasdaq: ISSI)
, is up nearly +20% today after topping estimates by a handy margin
for the fourth... Read >>